What is Vibrant Gastro?
Vibrant Gastro, Inc. operates at the intersection of medical technology and digestive health. The company is best known for its FDA-cleared Vibrant capsule, a sophisticated device that utilizes targeted micro-vibrations to stimulate the colon and improve bowel function. This innovation addresses a critical gap for patients who experience limited efficacy or adverse side effects from traditional laxative therapies. Recognized as one of TIME's Best Inventions of 2023, the Vibrant System offers a predictable, drug-free regimen that empowers patients to manage their digestive health with greater autonomy and comfort. The company's strategic focus remains on clinical validation and expanding access to this novel therapeutic modality.
How much funding has Vibrant Gastro raised?
Vibrant Gastro has raised a total of $7.5M across 1 funding round:
Series E
$7.5M
Series E (2021): $7.5M, investors not publicly disclosed
Key Investors in Vibrant Gastro
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Vibrant Gastro?
With this major strategic investment, Vibrant Gastro is well-positioned to accelerate its commercialization efforts and deepen its penetration into the chronic constipation market. The company is expected to prioritize scaling its manufacturing capabilities and expanding its clinical footprint to reach a broader patient demographic. As the firm transitions from early-stage development to a more mature enterprise-level operation, the focus will likely shift toward securing broader insurance coverage and establishing the Vibrant System as a standard-of-care alternative to conventional pharmaceutical treatments. Continued investment in clinical data will be essential to solidify its competitive advantage in the evolving landscape of gastrointestinal care.
See full Vibrant Gastro company page
